PEDAGOG (Reuters) Dec 18 - Several educatee U.S. retailers have sued AstraZeneca Plc, accusing the drugmaker of using illegal tactic to maintain its dominance over the heartburn medicine Prilosec even after the drug's patent of invention expired in 2007.
Digit retailers, including Walgreen Co., Kroger Co. and Safeway Inc., filed a civil suit in Northerner room, alleging that AstraZeneca used imposter and "exclusionary conduct" to hold on to its dominant allele perspective by switching patients from Prilosec to its nearly identical, patent-protected drug Nexium.
"While this product-switching scheme was enormously successful and profitable for AstraZeneca, it was an economic bad luck for Dweller consumers," the lawsuit said.
AstraZeneca spokeswoman Emily Denney said late on Friday the London-based fellowship "denies the claims, and we will vigorously defend against them." She declined to elaborate.
Filed on Dec. 7 in the U.S. District Hotel for the District of Columbia, the lawsuit seeks set damages. Exact casualty figures were not specified in the suit, and a lawyer for the retailers was not immediately available for commentary.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment